RecruitingNCT07058935
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)
Sponsor
National Heart Centre Singapore
Enrollment
150 participants
Start Date
Mar 17, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.
Eligibility
Min Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with valve disease, heart. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 21 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07058935
Related Trials
Nonintubated Anesthesia for Adult Cardiac Surgery With Cardiopulmonary Bypass
NCT07744009
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
NCT072249061 location
Medtronic Cardiac Surgery PMCF Registry
NCT0407342026 locations
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
NCT069175861 location
Valvular Heart Disease in Women Registry
NCT071969302 locations